Aromatase

Fatal Cardiac Events No Higher With Aromatase Inhibitors for Breast Cancer Therapy
In the last few years, at least two different meta-analyses have suggested that newer estrogen-lowering aromatase inhibitors used to prevent recurrence of breast cancer may increase the risk of developing cardiovascular disease. But a study published ... [...]
5
Like
Save
Aromatase Inhibitors Reduce Contralateral Breast Cancer
When compared with women who were not treated with endocrine therapy after breast cancer, women who took tamoxifen for four years or longer had a 61 percent reduced risk of developing another cancer in the opposite breast, stated Gretchen Gierach, ... [...]
3
Like
Save